MedPath

BIVALIRUDINA SALA 250 MG POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE O PERFUSION EFG

BIVALIRUDINA SALA 250 MG POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE O PERFUSION EFG

Commercialized
Register Number

80912

Prescription Type

Uso Hospitalario

Authorization Date

May 23, 2016

Dosage Form

POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number80912
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

BIVALIRUDINAActive
Quantity: 250 mg
Name: BIVALIRUDINA

ATC CLASSIFICATION (3)

B01A
B01AE
B01AE06

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.